Sivelestat sodium is one of 87 small molecule programs targeting Acute Ischemic Stroke. It is currently in Phase 3.
Indications
Total Trials
Active Trials
Competitors
Pipeline
Competition
350 competitors in Treatment
Sivelestat sodium
Dexilant
Alfenta
Niclocide
Hivid
Valium
Clomid
Aurlumyn
Lotemax
Norpramin
Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.
Timeline
Clinical
Sources
Details